| Page 883 | Kisaco Research

Group Digital Risk Manager, Legal and General

It was great to hear from industry peers and regulators the about the need for PETs. The best thing was the good balance of tech providing vendors and industry leaders sharing their thoughts during two days event.

Senior Data Privacy Technical Lead, Roche

I came to the conference not knowing much about PETs or their potential use or value. I came away knowing much more, heard many rich discussions and new thinking on how they might be applied in my own business area.

 

Lucho Lopez-May

CEO
The Kraft Heinz Not Company

Lucho Lopez-May

CEO
The Kraft Heinz Not Company

Lucho Lopez-May

CEO
The Kraft Heinz Not Company
 

Jan Stappers

Whistleblowing Expert & Associate Partner Development Director
NAVEX

An expert in organisational whistleblowing management, Jan is engaged in the development of the new ISO 37002 Standard, is a frequent speaker on subjects related to whistleblowing, and has authored various articles on new legislation concerning whistleblower protection, anti-corruption, and organisational whistleblowing best practices. Jan is CIPP/E is an International Association of Privacy Professionals (IAPP) Certified Information Privacy Professional (CIPP/E).

Jan Stappers

Whistleblowing Expert & Associate Partner Development Director
NAVEX

Jan Stappers

Whistleblowing Expert & Associate Partner Development Director
NAVEX

An expert in organisational whistleblowing management, Jan is engaged in the development of the new ISO 37002 Standard, is a frequent speaker on subjects related to whistleblowing, and has authored various articles on new legislation concerning whistleblower protection, anti-corruption, and organisational whistleblowing best practices. Jan is CIPP/E is an International Association of Privacy Professionals (IAPP) Certified Information Privacy Professional (CIPP/E). He holds a Postgraduate Diploma (PGDip) from King’s College London in the United Kingdom (EU Competition Law) and a master’s degree (LL.M) from Leiden University in the Netherlands (European Law).

 

Lena Stenberg Domeji

Director of Compliance
Bank of China

Lena Stenberg Domeji

Director of Compliance
Bank of China

Lena Stenberg Domeji

Director of Compliance
Bank of China
Pre-Clinical Program Competition T&Cs
 

Siamak Tavallaei

Advisor to the Board
CXL Consortium

Siamak Tavallaei has recently served as the CXL Consortium President and Chief Systems Architect at Google Cloud. Currently he is the CXL Advisor to the Board and the Incubation Committee (IC) member for OCP Server Project where he drives the architecture and productization of CXL-enabled solutions.

Siamak Tavallaei

Advisor to the Board
CXL Consortium

Siamak Tavallaei

Advisor to the Board
CXL Consortium

Siamak Tavallaei has recently served as the CXL Consortium President and Chief Systems Architect at Google Cloud. Currently he is the CXL Advisor to the Board and the Incubation Committee (IC) member for OCP Server Project where he drives the architecture and productization of CXL-enabled solutions. His current focus is the system optimization for large-scale, mega-datacenters for general-purpose and tightly-connected, accelerated machines built on co-designed hardware, software, security, and management.  In 2019, he joined CXL effort as a founding member where he first served as co-chair of Technical Task Force (TTF) and as the CXL President in 2021. In 2016, he joined OCP as a co-lead of Server Project and now is the Incubation Committee (IC) member where he drives open-sourced modular design concepts for integrated hardware/software solutions (OAI, DC-SCM, DC-MHS, and DC-Stack).  His experiences as Chief Systems Architect at Google, Principal Architect at Microsoft Azure, Distinguished Technologist at HP, and Principal Member of Technical Staff at Compaq along with his contributions to industry collaborations such as EISA, PCI, InfiniBand, and PCIe give Siamak a broad understanding of requirements and solutions for the Enterprise, Hyperscale, and Edge datacenters for industry-wide initiatives.

SGS Quay Pharmaceuticals

This was an intimate meeting with an excellent focus and presentations on the current state of Microbiome therapies and future prospects in the field.